Sign in to view content

Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept

Mark R. Barakat, MD

Video
Published 2022

Related

Ranibizumab Induces Regression of Diabetic Retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2016
Prospective Trial Comparing Ranibizumab Monthly to Treat and Extent With and Without Angiography-Guided Laser for DME
John F. Payne, MD
Updates from the Field
2016
Diabetic Retinopathy Progression in Anti-VEGF Versus Fluocinolone Acetonide Implant Treated Eyes Who Are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2020

Category: Pharmacology

See more